4.6 Review

Tau tubulin kinases in proteinopathy

Journal

FEBS JOURNAL
Volume 286, Issue 13, Pages 2434-2446

Publisher

WILEY
DOI: 10.1111/febs.14866

Keywords

ALS; Alzheimer's disease; CBD; FTLD; phosphorylation; Pick's disease; PSP; tau; tauopathy; TDP-43; TTBK1; TTBK2

Funding

  1. Department of Veterans Affairs [I01BX002619, I01BX007080, I01BX004044]
  2. National Institutes of Health [R01NS064131]
  3. NIA training grant [T32AG000057]

Ask authors/readers for more resources

A number of neurodegenerative diseases are characterized by deposition of abnormally phosphorylated tau or TDP-43 in disease-affected neurons. These diseases include Alzheimer's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis. No disease-modifying therapeutics is available to treat these disorders, and we have a limited understanding of the cellular and molecular factors integral to disease initiation or progression. Phosphorylated tau and TDP-43 are important markers of pathology in dementia disorders and directly contribute to tau- and TDP-43-related neurotoxicity and neurodegeneration. Here, we review the scope of tau and TDP-43 phosphorylation in neurodegenerative disease and discuss recent work demonstrating the kinases TTBK1 and TTBK2 phosphorylate both tau and TDP-43, promoting neurodegeneration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available